Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

34.04
-0.1290-0.38%
Volume:2K
Turnover:52.95K
Market Cap:13.62M
PE:- -
High:34.04
Open:34.00
Low:34.00
Close:34.17
52wk High:34.86
52wk Low:25.79
Shares:400.00K
Float Shares:400.00K
Volume Ratio:10.51
T/O Rate:0.39%
Dividend:0.08
Dividend Rate:0.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111

TIPRANKS
·
3 hours ago

Transthera-B Doses First Patient in Phase II Trial of Tinengotinib Combined with Novel Endocrine Therapy for Advanced Metastatic Castration-Resistant Prostate Cancer in China

Stock News
·
4 hours ago

Merck Says EU CHMP Backs Keytruda-Padcev Perioperative Use in Resectable Muscle-Invasive Bladder Cancer

Reuters
·
4 hours ago

Merck & Co - Final Ec Decision Expected by Q4 2026

THOMSON REUTERS
·
4 hours ago

Merck Receives Positive EU Chmp Opinion for Keytruda® (Pembrolizumab) Plus Padcev® (Enfortumab Vedotin-Ejfv) as Perioperative Treatment for Adults with Resectable Muscle-Invasive Bladder Cancer (Mibc)

THOMSON REUTERS
·
4 hours ago

Analysts Offer Insights on Healthcare Companies: Neuronetics (STIM), Xenon (XENE) and Biogen (BIIB)

TIPRANKS
·
4 hours ago

Merck Launches Your Hive of Whole Health to Support Whole Person Care for People Living with Hiv

THOMSON REUTERS
·
4 hours ago

Hefei Lifeon's Clinical Trial Application for a New Pain Relief Drug Combination Has Been Officially Accepted by the Regulator

Stock News
·
7 hours ago

Gan & Lee Pharmaceuticals Receives Clinical Trial Approval for Investigational Drug GLR1075 Injection

Stock News
·
7 hours ago

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
18 hours ago

Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
18 hours ago

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
18 hours ago

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

Dow Jones
·
18 hours ago

PepsiCo Adds Johnson & Johnson CEO Joaquin Duato to Board, Names Him to Audit Committee

Reuters
·
18 hours ago

Biogen publishes results from adolescent subgroup of VALIANT study

TIPRANKS
·
18 hours ago

Ultragenyx confirms FDA approval of Fayuvi

TIPRANKS
·
19 hours ago

Moderna: Another Day, Another Big Stock Move. is the Cancer Vaccine Rally Back On?

Dow Jones
·
22 hours ago

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

TIPRANKS
·
Yesterday

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

TIPRANKS
·
Yesterday

Genetic Signatures Faces Shareholder-Requested Vote on Director Removal

TIPRANKS
·
Yesterday